The main aim of the project is to gain further knowledge of the health and nutritional benefits of the products, along with an investigation into their bioactive properties. To achieve this, the research activities are divided into two main areas:
- Feeding trials with inclusion of Calanus® Hydrolysate and Calanus® Powder in the feed to marine fish and shrimp. Analytical criteria in the trials include growth, survival, FCR, palatability/attractability, intestinal health, immune system, microbiome, and skeletal development. The model organisms will be European seabass and Litopenaeus vannamei.
- Identification of bioactive peptides in Calanus® Hydrolysate using bioassays and cell cultures, and characterization of identified peptides using mass spectrometry methods. The main focus is on peptides promoting skeletal muscle development in salmon.
With financing from The Norwegian Research Council, the project has a duration of four years from 2020 to 2024. The degree-conferring institution will be University of Tromsø (UiT) Arctic University of Norway, and research institute Nofima will function as an industrial collaborator. Dr. Karl-Erik Eilertsen of Faculty of biosciences, fisheries and economics, UiT is the main supervisor, and Dr. Alice Marie Pedersen of Calanus AS and Dr. Sileshi Wubshet of Nofima are co-supervisors in the project.